Foseco Crucible (India) Ltd
- Market cap
- ₹ 972 Cr.
- P/E
- 66.5x
- P/B
- 7.41x
- 52-week range
- 1,155 – 2,115
- ROE
- 22%
- ROCE
- 33%
- Dividend yield
- 0.7%
- Debt / equity
- 0.01
- Sector
- Industrial Products
- Industry
- Electrodes & Refractories
- Listed on
- BSE
About
Foseco Crucible (India) Limited, formerly Morganite Crucible (India) Limited, is an India-based manufacturer of high-performance crucibles, foundry consumables and allied refractory products. The Company’s product offerings include silicon carbide crucibles, clay graphite crucibles, and a range of foundry and allied products for the ferrous and non-ferrous metal industries. Its product is designed to match the specific characteristics and operational requirements of its customers' metal melting, holding or transfer applications. Its products include Suprex, Salamander, Excel & Himelt, Nozzle, Morcem Cement, Tubes & Plunger Mix, and Stopper Rods and Heads. Its geographical segments include India and Outside India. Outside India segment includes Asia and the Far East, Europe, Africa and Middle East, America and others. Its diversified portfolio caters to a range of industries such as mining, automotive, industrial machinery, electrical equipment and railways.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Electrodes & Refractories: 16 companies →Foseco Crucible (India) Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)66.5 against a typical 28.7: pricier than most peers (1st = cheapest).14th of 16
- Sales growth+14% against a typical +5.7% from a year earlier.4th of 14
- Profit growth+66.7% against a typical +55.8% from a year earlier.5th of 14
- Share price, 3 months+39% against a typical +3.4%.5th of 15
- Size₹ 971.8 Cr. market value against a typical ₹ 971.8 Cr. (1st = largest).8th of 15
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 45 | 40 | 40 | 43 | 44 | 45 | 42 | 43 | 46 | 46 | 37 | 49 |
| Expenses | 33 | 32 | 34 | 32 | 31 | 34 | 36 | 33 | 33 | 32 | 28 | 30 |
| Operating Profit | 13 | 8 | 6 | 11 | 13 | 10 | 7 | 9 | 13 | 14 | 10 | 18 |
| OPM % | 28% | 21% | 14% | 25% | 29% | 23% | 15% | 21% | 28% | 31% | 26% | 37% |
| Other Income | 1 | 3 | −2 | 2 | 2 | 3 | 2 | 2 | 3 | −2 | −10 | −1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit before tax | 12 | 9 | 1 | 11 | 12 | 11 | 5 | 8 | 12 | 9 | −3 | 15 |
| Tax % | 29% | 27% | 47% | 26% | 28% | 28% | 47% | 32% | 29% | 37% | −57% | 31% |
| Net Profit | 8 | 7 | 1 | 8 | 9 | 8 | 3 | 6 | 9 | 6 | −1 | 10 |
| EPS in Rs | 14.84 | 11.91 | 1.25 | 14.11 | 15.93 | 14.02 | 5.14 | 10.3 | 15.68 | 9.95 | −2.5 | 18.38 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 7%
- 5 Years
- 10%
- 3 Years
- 4%
- TTM
- 2%
- 10 Years
- 12%
- 5 Years
- 126%
- 3 Years
- 23%
- TTM
- 55%
- 10 Years
- 17%
- 5 Years
- 11%
- 3 Years
- 3%
- TTM
- —
- 10 Years
- 18%
- 5 Years
- 21%
- 3 Years
- 21%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Foseco Crucible (India) Ltd | ₹ 1,939.30 | ₹ 972 Cr. | 66.5x | 7.4x | 22% | — |
| UltraTech Cement | ₹ 11,066.00 | ₹ 3,26,092 Cr. | 41.7x | 4.5x | 11.1% | 9.3% |
| Grasim Industries | ₹ 2,898.00 | ₹ 1,95,975 Cr. | 40.8x | 2x | 4.9% | 5.9% |
| Ambuja Cements | ₹ 358.00 | ₹ 88,956 Cr. | 21.9x | 1.8x | 8.3% | 13.8% |
| Shree Cement | ₹ 22,760.00 | ₹ 82,120 Cr. | 55.2x | 4.1x | 7.8% | 8.4% |
| Dalmia Bharat | ₹ 1,591.65 | ₹ 29,801 Cr. | 29.5x | 1.9x | 6.5% | 7.8% |
Management
- Mohit Mangal
- Chief Financial Officer
- Pooja Jindal
- Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.